z-logo
open-access-imgOpen Access
Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells
Author(s) -
Niphat Jirapongwattana,
Suyanee Thongchot,
Wannasiri Chiraphapphaiboon,
Thaweesak Chieochansin,
Doonyapat Sa-nguanraksa,
Malee Warnnissorn,
Peti Thuwajit,
Pathai Yenchitsomanus,
Chanitra Thuwajit
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8338
Subject(s) - mesothelin , cancer research , triple negative breast cancer , cancer cell , biology , cancer , immunology , medicine , breast cancer , antigen

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom